Structure of Mesorhizobium loti arylamine N-acetyltransferase 1

被引:39
作者
Holton, SJ
Dairou, J
Sandy, J
Rodrigues-Lima, F
Dupret, JM
Noble, MEM
Sim, E
机构
[1] Univ Oxford, Dept Biochem, Lab Mol Biophys, Oxford OX1 3QT, England
[2] Univ Paris 06, CNRS, UMR 7000, F-75013 Paris, France
[3] Univ Paris 07, UFR Biochim, F-75005 Paris, France
来源
ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS | 2005年 / 61卷
基金
英国惠康基金;
关键词
D O I
10.1107/S1744309104030659
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The arylamine N-acetyltransferase (NAT) enzymes have been found in a broad range of both eukaryotic and prokaryotic organisms. The NAT enzymes catalyse the transfer of an acetyl group from acetyl Co-enzyme A onto the terminal nitrogen of a range of arylamine, hydrazine and arylhydrazine compounds. Recently, several NAT structures have been reported from different prokaryotic sources including Salmonella typhimurium, Mycobacterium smegmatis and Pseudomonas aeruginosa. Bioinformatics analysis of the Mesorhizobium loti genome revealed two NAT paralogues, the first example of multiple NAT isoenzymes in a eubacterial organism. The M. loti NAT 1 enzyme was recombinantly expressed and purified for X-ray crystallographic studies. The purified enzyme was crystallized in 0.5 M Ca(OAc)(2), 16% PEG 3350, 0.1 M Tris-HCI pH 8.5 using the sitting-drop vapour-diffusion method. A data set diffracting to 2.0 A was collected from a single crystal at 100 K. The crystal belongs to the orthorhombic spacegroup P2(1)2(1)2(1), with unit-cell parameters a = 53.2, b = 97.3, c = 114.3 A. The structure was refined to a final free-R factor of 24.8%. The structure reveals that despite low sequence homology, M. loti NAT1 shares the common fold as reported in previous NAT structures and exhibits the same catalytic triad of residues (Cys-His-Asp) in the active site.
引用
收藏
页码:14 / 16
页数:3
相关论文
共 16 条
[1]   THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY [J].
BAILEY, S .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 :760-763
[2]   Identification and functional characterization of arylamine N-acetyltransferases in eubacteria:: Evidence for highly selective acetylation of 5-aminosalicylic acid [J].
Deloménie, C ;
Fouix, S ;
Longuemaux, S ;
Brahimi, N ;
Bizet, C ;
Picard, B ;
Denamur, E ;
Dupret, JM .
JOURNAL OF BACTERIOLOGY, 2001, 183 (11) :3417-3427
[3]  
EVANS DAP, 1989, PHARMACOL THERAPEUT, V42, P157
[4]   IMPROVED METHODS FOR BUILDING PROTEIN MODELS IN ELECTRON-DENSITY MAPS AND THE LOCATION OF ERRORS IN THESE MODELS [J].
JONES, TA ;
ZOU, JY ;
COWAN, SW ;
KJELDGAARD, M .
ACTA CRYSTALLOGRAPHICA SECTION A, 1991, 47 :110-119
[5]  
Kaneko T, 2000, DNA RES, V7, P331, DOI 10.1093/dnares/7.6.331
[6]   PROCHECK - A PROGRAM TO CHECK THE STEREOCHEMICAL QUALITY OF PROTEIN STRUCTURES [J].
LASKOWSKI, RA ;
MACARTHUR, MW ;
MOSS, DS ;
THORNTON, JM .
JOURNAL OF APPLIED CRYSTALLOGRAPHY, 1993, 26 :283-291
[7]   Eubacterial arylamine N-acetyltransferases -: identification and comparison of 18 members of the protein family with conserved active site cysteine, histidine and aspartate residues [J].
Payton, M ;
Mushtaq, A ;
Yu, TW ;
Wu, LJ ;
Sinclair, J ;
Sim, E .
MICROBIOLOGY-SGM, 2001, 147 :1137-1147
[8]   Automated protein model building combined with iterative structure refinement [J].
Perrakis, A ;
Morris, R ;
Lamzin, VS .
NATURE STRUCTURAL BIOLOGY, 1999, 6 (05) :458-463
[9]   The pharmacogenetics of NAT: structural aspects [J].
Pompeo, F ;
Brooke, E ;
Kawamura, A ;
Mushtaq, A ;
Sim, E .
PHARMACOGENOMICS, 2002, 3 (01) :19-30
[10]  
RIDDLE B, 1971, J BIOL CHEM, V246, P3250